Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV+ DLBCL-NOS: a Chinese cohort study
Tong‐Yao Xing(Jiangsu Province Hospital), Wei Xu(Jiangsu Province Hospital), Kai‐Xin Du(Jiangsu Province Hospital), Zi‐Wen Duan(Jiangsu Province Hospital), Yue Li(Southwest Petroleum University), Jianyong Li(Jiangsu Province Hospital), Hua Yin(Jiangsu Province Hospital), Wei‐Ting Wang(Institute of Molecular Biology, Academia Sinica), Jia‐Zhu Wu(Augusta University Health), Jin‐Hua Liang(Broad Institute), Li Wang(University of Science and Technology of China), Hao-Rui Shen(Nanjing Medical University)
Cited by 3
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U
|The Journal of Experimental Medicine|2010|240
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|238